FOLH1 and prostate carcinoma: Regardless of the feasibility and outcome of alternative therapies, at present, there is an increasing interest for salvage re-irradiation of PSMA-detected local relapses even before PSA relapse becomes apparent, especially since early predictors of pending relapse after prostate cancer radiotherapy are emerging (22).